Japan’s OMRON Healthcare has began manufacturing blood stress screens at its first Indian manufacturing unit close to Chennai. The corporate plans to develop manufacturing tenfold by 2028 and steadily introduce smarter manufacturing expertise.
House healthcare gadgets equivalent to blood stress screens have gotten more and more necessary as extra individuals look to maintain observe of their well being past hospital visits. Nevertheless, entry to dependable monitoring tools stays a problem for a lot of households in India. In a transfer that might strengthen the nation’s medical gadget manufacturing sector, Japan-based OMRON Healthcare has began full-scale manufacturing at its first manufacturing unit in India, close to Chennai, Tamil Nadu. The ability will initially manufacture blood stress screens for the home market, with plans to develop manufacturing and ultimately serve worldwide markets. The corporate can be trying to introduce smarter manufacturing expertise because it strengthens its presence in India.
OMRON begins blood stress monitor manufacturing at its first India manufacturing unit
Situated at ORIGINS by Mahindra close to Chennai, the roughly 24,000-square-metre facility is operated by OMRON Healthcare Manufacturing India Pvt. Ltd. It started full-scale manufacturing in October 2026 and at the moment has 5 manufacturing traces devoted to manufacturing blood stress screens.
The manufacturing unit produces three sequence: HEM-7090, HEM-7181 and HEM-7183T. These embody normal upper-arm screens designed for first-time customers, fashions with reminiscence features and Development Indicator alerts, and Bluetooth-enabled gadgets that join with the OMRON Join well being administration app.
In response to the corporate, the ability follows manufacturing applied sciences and quality-control practices developed at its manufacturing models in Matsusaka, Japan, and Vietnam. That is supposed to make sure that gadgets manufactured in India meet the identical measurement accuracy and high quality requirements as these equipped to worldwide markets.
The ability additionally helps the federal government’s Make in India initiative via native part sourcing, workforce improvement and employment era. Established in July 2022, the manufacturing unit has a workforce of roughly 120 staff and a capitalisation of Rs 1.91 billion.
OMRON plans to extend manufacturing tenfold by 2028
The corporate goals to extend the Chennai manufacturing unit’s manufacturing capability tenfold by 2028, focusing on an annual output of round three million blood stress screens.
Initially, the whole manufacturing will cater to Indian shoppers. Nevertheless, OMRON plans to steadily develop Chennai into a producing and provide base for worldwide markets. This enlargement can be anticipated to diversify its international manufacturing community and cut back its dependence on Vietnam as a significant manufacturing base.
Ayumu Okada, President and CEO of OMRON Healthcare Co. Ltd., mentioned the corporate desires to strengthen native manufacturing whereas constructing a secure provide of medical-grade blood stress screens for India.
The corporate additionally plans to introduce nebuliser manufacturing on the facility. These gadgets are generally used to ship prescribed medicine via a advantageous mist for individuals with respiratory situations equivalent to bronchial asthma.
Chennai facility could steadily develop into a wise manufacturing hub
Past rising manufacturing, OMRON is planning to introduce smarter manufacturing capabilities on the Chennai facility. The corporate intends to steadily combine expertise and automation into manufacturing processes to enhance effectivity, high quality and operational consistency.
You might also like
Nevertheless, the transition won’t contain utterly automated manufacturing from the start. Human experience and supervision will proceed to play an necessary function, significantly as a result of medical gadgets require precision and constant high quality checks.
In response to Ayumu Okada, the corporate goals to mix technology-led manufacturing with human oversight moderately than rely solely on automated techniques.
OMRON has not but shared an in depth timeline or particular expertise investments for this transition. Its broader India technique focuses on manufacturing innovation and digital well being, with the goal of growing healthcare options that make use of related applied sciences.
Why is OMRON increasing its manufacturing presence in India?
India’s rising hypertension burden is likely one of the key elements behind the corporate’s enlargement. OMRON estimates that roughly 300 million individuals within the nation reside with hypertension, whereas fewer than 5 p.c of households usually use a house blood stress monitor.
The corporate at the moment holds roughly 40 p.c of India’s dwelling blood stress monitor market, based on reported firm estimates for 2025.
By rising native manufacturing, OMRON goals to strengthen product availability and assist wider adoption of dwelling blood stress monitoring. The corporate has been working in India since 2010 and has collaborated with the Indian Society of Hypertension on the event of the nation’s first dwelling blood stress monitoring tips.
The Chennai manufacturing unit, due to this fact, represents greater than an enlargement of producing capability. With plans for increased manufacturing, native sourcing, good manufacturing and worldwide provide, OMRON is trying to make India a extra important a part of its international healthcare manufacturing operations.
